Free shipping on all orders over $ 500

UDP disodium salt

Cat. No. M7452

All AbMole products are for research use only, cannot be used for human consumption.

UDP disodium salt Structure
Size Price Availability Quantity
100mg USD 55  USD55 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

UDP disodium salt is a endogenous P2Y receptor agonist which preferentially activates P2Y6. Shown to be a competitive antagonist at P2Y14 receptors.

Chemical Information
Molecular Weight 448.12
Formula C9H12N2Na2O12P2
CAS Number 27821-45-0
Form Solid
Solubility (25°C) Water 44.81 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Famaey. Inflamm Res. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.

Related P2 Receptor Products
NF449 

NF449 is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

NF279 

NF279 is a potent selective and reversible P2X1 receptor antagonist, with an IC50 of 19 nM.

NF110 

NF110 is a P2X3 receptor antagonist (Ki = 36 nM) and inactive toward P2Y receptors stably expressed (IC50s > 10 M).

PSB-12062

PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

NF449 octasodium 

NF449 octasodium is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: UDP disodium salt supplier, P2 Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.